NDC 50458-940 – Invokamet Xr
Canagliflozin 50 mg/1; Metformin Hydrochloride 500 mg/1 · Tablet, Film Coated, Extended Release · Oral
Product NDC50458-940
Product details
- Brand name
- Invokamet Xr
- Generic name
- Canagliflozin and metformin hydrochloride
- Labeler
- Janssen Pharmaceuticals, Inc.
- Dosage form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA205879
- Marketed since
- September 20, 2016
- Listing expires
- December 31, 2027
- Pharmacologic class
- Biguanide; Sodium-Glucose Cotransporter 2 Inhibitor
Active ingredients
- Canagliflozin 50 mg/1
- Metformin Hydrochloride 500 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50458-940-01 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-940-01) | Sep 20, 2016 |
Recalls mentioning this NDC
- D-0115-2017 Nov 2, 2016 · Class III
Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert.
Other Invokamet Xr products
- 50458-941 Canagliflozin 50 mg/1; Metformin Hydrochloride 1000 mg/1 · Tablet, Film Coated, Extended Release · Janssen Pharmaceuticals, Inc.
- 50458-942 Canagliflozin 150 mg/1; Metformin Hydrochloride 500 mg/1 · Tablet, Film Coated, Extended Release · Janssen Pharmaceuticals, Inc.
- 50458-943 Canagliflozin 150 mg/1; Metformin Hydrochloride 1000 mg/1 · Tablet, Film Coated, Extended Release · Janssen Pharmaceuticals, Inc.